has proved oxygen supplement can efficiently weaken the hypoxia-adenosine axis, enhancing the intratumoral infiltration and antitumor response of endogenously developed or adoptively transferred tumor-reactive CD8+ T cells (124). The gene discussed is CD8A; the disease is neoplasm.